Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Michael Heffernan Member of the Audit Committee Chair of the Nominating & Governance Committee Michael Heffernan Synlogic Announces Pricing of Public Offering of Common Stock Read more about Synlogic Announces Pricing of Public Offering of Common Stock Synlogic Announces Proposed Public Offering of Common Stock Read more about Synlogic Announces Proposed Public Offering of Common Stock Synlogic Presents Data Demonstrating Activity of a Solid Oral Formulation of SYNB1618 at American College of Medical Genetics (ACMG) Annual Meeting Read more about Synlogic Presents Data Demonstrating Activity of a Solid Oral Formulation of SYNB1618 at American College of Medical Genetics (ACMG) Annual Meeting Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting Read more about Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting Synlogic to Present at Upcoming Virtual Banking and Industry Conferences Read more about Synlogic to Present at Upcoming Virtual Banking and Industry Conferences Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update Read more about Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria Read more about Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria Synlogic Announces Fourth Quarter and Full Year 2020 Conference Call & Webcast Read more about Synlogic Announces Fourth Quarter and Full Year 2020 Conference Call & Webcast Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership Team Read more about Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership Team Pagination First page « First Previous page ‹ Previous … Page 6 Page 7 Page 8 Page 9 Current page 10 Page 11 Page 12 Page 13 Page 14 … Next page Next › Last page Last » Subscribe to Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Michael Heffernan Member of the Audit Committee Chair of the Nominating & Governance Committee Michael Heffernan
Synlogic Announces Pricing of Public Offering of Common Stock Read more about Synlogic Announces Pricing of Public Offering of Common Stock
Synlogic Announces Proposed Public Offering of Common Stock Read more about Synlogic Announces Proposed Public Offering of Common Stock
Synlogic Presents Data Demonstrating Activity of a Solid Oral Formulation of SYNB1618 at American College of Medical Genetics (ACMG) Annual Meeting Read more about Synlogic Presents Data Demonstrating Activity of a Solid Oral Formulation of SYNB1618 at American College of Medical Genetics (ACMG) Annual Meeting
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting Read more about Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
Synlogic to Present at Upcoming Virtual Banking and Industry Conferences Read more about Synlogic to Present at Upcoming Virtual Banking and Industry Conferences
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update Read more about Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria Read more about Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria
Synlogic Announces Fourth Quarter and Full Year 2020 Conference Call & Webcast Read more about Synlogic Announces Fourth Quarter and Full Year 2020 Conference Call & Webcast
Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership Team Read more about Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership Team